Complete response to exemestane in a patient with a desmoid tumor

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)

(2011) D. Garbay et al.   ANNALS OF ONCOLOGY

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

(2010) N. Penel et al.   ANNALS OF ONCOLOGY

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

(2010) Rob Riemsma et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Receptors: Therapies Targeted to Receptor Subtypes

(2010) S Nilsson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Early recurrence risk: aromatase inhibitors versus tamoxifen

(2010) Emilio Bria et al.   Expert Review of Anticancer Therapy

Aromatase inhibition in male breast cancer patients: biological and clinical implications

(2009) J. Doyen et al.   ANNALS OF ONCOLOGY

Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment

(2009) Marco Fiore et al.   ANNALS OF SURGICAL ONCOLOGY

ERβ in breast cancer—Onlooker, passive player, or active protector?

(2008) Emily M. Fox et al.   STEROIDS

Treatment of aggressive angiomyxoma with aromatase inhibitor prior to surgical resection

(2007) D.L. GILES et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER